- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia, Myelogenous, Chronic, BCR-ABL Positive in New Zealand
Total 701 results
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Australia, Germany, United Kingdom
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Kura Oncology, Inc.CompletedLeukemia, Myelomonocytic, ChronicUnited States
-
Pharmacyclics LLC.CompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Alexion PharmaceuticalsTerminatedMultiple Myeloma | B-cell Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Kirby InstituteCelgeneActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
BioCryst PharmaceuticalsCompletedChronic Lymphocytic Leukemia (CLL)United States, Australia
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's SyndromeUnited States, United Kingdom, Italy
-
WiSP Wissenschaftlicher Service Pharma GmbHMundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbHCompletedChronic Lymphocytic LeukemiaGermany
-
Weill Medical College of Cornell UniversityGenentech, Inc.; BeiGeneRecruitingLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; SWOG Cancer Research...CompletedStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Zhejiang DTRM BiopharmaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter's Transformation | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States, Spain, Korea, Republic of, Australia, Canada, Germany, France, United Kingdom, Italy
-
GlaxoSmithKlineNational Cancer Institute (NCI)Completed
-
US Oncology ResearchAstex Pharmaceuticals, Inc.CompletedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden
-
Carevive Systems, Inc.RecruitingBreast Cancer | Multiple Myeloma | Ovarian Cancer | Lung Cancer | Acute Myelogenous LeukemiaUnited States
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)TerminatedLymphoma | LeukemiaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicAustralia, Brazil, Spain, Italy, Canada, Germany, Chile, Mexico, France, Argentina, Croatia, Russian Federation, Slovakia, Turkey, Poland, Czechia, New Zealand, Portugal, Greece
-
Eisai Inc.CompletedLeukemia, Lymphocytic, ChronicCanada, Australia, United States, Argentina, Brazil
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Myelomonocytic Leukemia-2United States
-
BiogenTerminatedChronic Lymphocytic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedJuvenile Myelomonocytic LeukemiaUnited States, Canada, Australia, New Zealand
-
Genentech, Inc.Active, not recruitingLymphocytic Leukemia, Chronic | Lymphoma, Non HodgkinUnited States, Korea, Republic of, Australia, United Kingdom, Germany, Canada, Spain
-
NextCure, Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic Leukemia | Relapsed or Refractory Myelodysplastic SyndromeUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic LymphomaUnited States, Italy
-
AstraZenecaCompletedChronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell LymphomaIndia
-
Genentech, Inc.CompletedLymphocytic Leukemia, ChronicUnited States
-
Hoffmann-La RocheAbbVieCompletedChronic Lymphocytic LeukemiaHungary, Spain, France, United Kingdom, United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, Germany, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Genentech, Inc.; Biologics, Inc.CompletedLymphoma | LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterPediatric Brain Tumor ConsortiumTerminatedFanconi Anemia | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML)United States
-
University of RochesterGlaxoSmithKlineCompletedChronic Lymphocytic Leukemia (CLL) | Waldenstrom Macroglobulinemia (WM)United States
-
TG Therapeutics, Inc.Memorial Sloan Kettering Cancer CenterCompletedChronic Lymphocytic Leukemia | Richter SyndromeUnited States
-
University of RochesterCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States, Puerto Rico, Israel
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, Belgium, Brazil, Poland, United Kingdom, Canada, Germany, Australia, Israel, Hungary, France, New Zealand, Chile, Lithuania, Sweden, Colombia
-
Bristol-Myers SquibbTerminatedLymphoma | Leukemia, Lymphocytic, Chronic, B-CellSpain, United States
-
Pharmacyclics LLC.Janssen, LPCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Leukemia Research FundMedical Research CouncilCompletedLeukemiaUnited Kingdom, Italy, New Zealand, Ireland, Croatia, Russian Federation, Greece, Argentina
-
CelgeneCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, United States, Italy, Germany, Austria
-
Treadwell Therapeutics, IncRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | AML | MDS | CMMLHong Kong, United States, Canada
-
Sumitomo Pharma America, Inc.TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLLUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedAnemia | Chronic Myelomonocytic Leukemia | Adult Myelodysplastic SyndromeUnited States
-
Gilead SciencesTerminatedLymphoma, Non-Hodgkin | Chronic Lymphocytic LeukemiaUnited States
-
Prelude TherapeuticsTerminatedFollicular Lymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Myeloproliferative Neoplasm | Small Lymphocytic Lymphoma | B-cell Non-Hodgkin LymphomaUnited States
-
BiogenTerminatedChronic Lymphocytic LeukemiaFrance, United States, Belgium, Australia, Austria, Poland, Canada, United Kingdom